Blood parameters and whole-blood transcriptomics associated with immune-related adverse events in metastatic renal cell carcinoma during nivolumab plus ipilimumab. - Kinase S; Nagumo Y; Isoda B; Sakurai H; Takahashi R; Suzuki S; Yamaguchi A; Yanagihashi R; Tanuma K; Nitta S; Shiga M; Kojo K; et al. (Scientific reports, 2026)